Trial
NCT04840472
Study Evaluating 111In-Panitumumab for Nodal Staging in Head and Neck Cancer
Phase ISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Stanford University
Collaborators
American Cancer Society, Inc.
Condition
Head and Neck Cancer
Intervention
111I-n panitumumab
Why stopped
tentatively suspended until drug manufacturing is available
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-24